Baxter International Inc/ US0718131099 /
08/08/2024 20:12:32 | Chg. +0.71 | Volume | Bid20:12:32 | Ask20:12:32 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
37.30USD | +1.94% | 1.27 mill. Turnover: 36.21 mill. |
37.29Bid Size: 100 | 37.31Ask Size: 400 | 18.84 bill.USD | 3.13% | 7.07 |
GlobeNewswire
26/06
Neurona Therapeutics Appoints Dr. Nadia Agopyan as Senior Vice President of Regulatory Affairs
GlobeNewswire
20/06
ProvisionAi COO Terri Bennett Robbins Named One of 20 Women Reshaping the Future of Logistics and th...
GlobeNewswire
20/06
E-fuels offer long-term solution to key energy transition transport sectors, but journey needs to st...
GlobeNewswire
14/06
CMS Improves Star Ratings to 3.5 Stars for Clover Health PPO Medicare Advantage Plans for 2025 Payme...
GlobeNewswire
12/06
2024 RealTrends + Tom Ferry The Thousand List Recognizes 44 eXp Realty Agents and Teams
GlobeNewswire
12/06
2024 Report: LGBTQ+ Advertising Influential Over Brand Perceptions & Purchase Decisions
GlobeNewswire
04/06
Wood Mackenzie appoints Xizhou Zhou as new head of Power and Renewables Business
GlobeNewswire
16/05
US November election results could decelerate energy transition, with $1 trillion in energy investme...
GlobeNewswire
15/05
Investigation Alert Baxter International, Eagle Pharmaceuticals, BioXcel Therapeutics, and ImmunityB...